诺基诺的使用和发作风险:基于人口的队列研究
Paraskevi Tassopoulou1, Annika Vivirito2, Philipp Heinemann2
1Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
概括
在大量人群研究中,诺基诺一般不会增加发作风险. 然而,对于患有慢性病的患者来说,风险可能会增加.
科学领域:
- 药物监督 药物监督 药物监督
- 中枢神经系统疾病 中枢神经系统疾病
- 传染性疾病 传染性疾病
背景情况:
- 众所周知,诺基诺具有中枢神经系统 (CNS) 刺激作用.
- 诺基诺使用与发作之间的关联需要在大量人群中进一步调查.
研究的目的:
- 与阿莫西西林相比,评估与诺基诺隆启动相关的发作风险.
- 识别具有修改风险的潜在子组.
主要方法:
- 一个基于人口的队列研究,使用德国索赔数据 (2016-2023年).
- 3,250,916名患者开始服用诺基诺或阿莫西西林,被跟踪了30天.
- 逆治疗概率加权和Cox比例危险模型被用于分析,其中宏类是二次比较物.
主要成果:
- 诺基诺与整体发作风险的增加无关 (HR,1.10;95% CI,0.995-1.23).
- 在老年人,没有先前的患者和患有慢性病的患者中观察到风险增加.
- 使用宏类的二次分析没有显示出整体相关性,但慢性病患者的潜在风险增加 (HR,1.65;95% CI,1.03-2.63).
结论:
- 诺基诺与整体发作风险的增加无关.
- 在患有慢性脏病的患者中,诺基诺使用可能会增加发作的风险.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Antiepileptic Drugs: Potassium Channel Activators
611
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
611
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
353
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
353


